ストックスクリーナーアプリを入手
11.29
2.08%
0.23
前日終値:
$11.06
開ける：
$11
24時間の取引高:
431.99K
Relative Volume:
0.71
時価総額：
$611.00M
収益：
$2.81M
当期純損益:
$-97.34M
株価収益率:
-7.1456
EPS:
-1.58
ネットキャッシュフロー:
$-91.47M
1週間 パフォーマンス:
+30.52%
1か月 パフォーマンス:
+16.39%
6か月 パフォーマンス:
+80.64%
1年 パフォーマンス:
+280.13%
1日の値動き範囲:
$10.75
$11.31
1週間の範囲:
$8.46
$12.19
52週間の値動き範囲:
$2.315
$12.19
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
名前
Fulcrum Therapeutics Inc
セクター
電話
617-651-8851
住所
26 LANDSDOWNE STREET, CAMBRIDGE, MA
FULC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FULC
Fulcrum Therapeutics Inc
|
11.29 | 598.55M | 2.81M | -97.34M | -91.47M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-29 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-05-23 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-05-15 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2024-09-13 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-09-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-09-12 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-09-12 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-09-12 | ダウングレード | Stifel | Buy → Hold |
| 2024-09-09 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-05-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-09-25 | 開始されました | Goldman | Neutral |
| 2023-08-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-08-22 | アップグレード | Stifel | Hold → Buy |
| 2023-05-04 | ダウングレード | Goldman | Buy → Neutral |
| 2023-03-10 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2023-03-10 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-03-09 | ダウングレード | Stifel | Buy → Hold |
| 2023-02-28 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-02-24 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-11-15 | 開始されました | Goldman | Buy |
| 2022-03-08 | 開始されました | Oppenheimer | Outperform |
| 2022-03-03 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-08-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-03-22 | 開始されました | Credit Suisse | Outperform |
| 2021-03-02 | 開始されました | Stifel | Buy |
| 2020-10-16 | 開始されました | Piper Sandler | Overweight |
| 2020-08-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-08-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-08-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-19 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2019-10-03 | 開始されました | H.C. Wainwright | Buy |
| 2019-08-12 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Fulcrum Therapeutics Inc (FULC) 最新ニュース
Insider Sell Alert: Robert Gould Sells 15,000 Shares of Fulcrum Therapeutics Inc (FULC) - GuruFocus
Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC) and Arrowhead Pharmaceuticals (ARWR) - The Globe and Mail
Will Fulcrum Therapeutics Inc. stock deliver consistent dividends2025 Winners & Losers & Long-Term Growth Plans - newser.com
How Fulcrum Therapeutics Inc. stock valuations compare to rivals2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
Will Fulcrum Therapeutics Inc. stock gain from strong economyRate Hike & Low Risk Entry Point Tips - newser.com
How Fulcrum Therapeutics Inc. stock compares to growth peersEarnings Recap Report & Real-Time Volume Triggers - newser.com
Fulcrum Therapeutics Inc. stock outlook for YEAR2025 Year in Review & Stock Portfolio Risk Control - newser.com
Is Fulcrum Therapeutics Inc. stock attractive for passive investorsJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Will Fulcrum Therapeutics Inc. stock beat EPS estimatesQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
This Biotech Just Lost Half Its Value As Its Rival Celebrated - Investor's Business Daily
Identifying reversal signals in Fulcrum Therapeutics Inc.Weekly Market Report & Verified Stock Trade Ideas - newser.com
Momentum divergence signals in Fulcrum Therapeutics Inc. chartTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
Multi asset correlation models including Fulcrum Therapeutics Inc.Quarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Datanomix and Fulcrum Modernize Manufacturing Tech Stacks with Seamless ERP + Production Monitoring Integration - GlobeNewswire Inc.
How Fulcrum Therapeutics Inc. stock responds to policy changesQuarterly Performance Summary & Accurate Trade Setup Notifications - newser.com
Tick level data insight on Fulcrum Therapeutics Inc. volatilityBond Market & Daily Growth Stock Tips - newser.com
Take off with Fulcrum Therapeutics Inc (FULC): Get ready for trading - Setenews
Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Fulcrum Therapeutics (FULC) Price Target Increased by 11.55% to 13.90 - Nasdaq
Bailard Inc. Takes Position in Fulcrum Therapeutics, Inc. $FULC - Defense World
Can Fulcrum Therapeutics Inc. stock resist sector downturns2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com
Fulcrum Therapeutics Inc (FULC) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):